German startup Qrago bags €2.7M to optimise healthcare logistics and patient transport

Stuttgart-based Qrago, a provider of software solutions in healthcare logistics and patient transport, has secured €2.7M in a seed funding round.

The new investment was led by VC funds āltitude and MobilityFund, with participation from existing investors including Segenia Capital and capacura.

āltitude is a pan-European pre-seed/seed fund investing in startups that are accelerating the digital transformation of SMEs.

Ingo Drexler, General Partner at āltitude says, “With its specialised logistics platform for the healthcare market, Qrago has already established itself in a strong position, but we still see enormous growth potential for the company in the future.“

Based out of Hamburg, MobilityFund is a BaFin-registered venture capital fund based in Hamburg, dedicated to driving the mobility transition.

The German company will use the funds to expand its reach in the DACH region and to grow its portfolio of logistics services offered.

Besides funding, the company has also announced that it has achieved C5 certification by the German Federal Office for Information Security (BSI), confirming its adherence to the highest security standards for cloud-based services.

Additionally, the company has also announced new partnerships with companies such as Uber (transport) and Debeka (health insurance), strengthening its service offering and the reach of its digital platform.

Qrago: Patient mobility in healthcare 

Led by Alexander Kunze and Christian Ruff, Qrago provides software solutions in the healthcare sector that optimises the transport of patients, laboratory samples, and materials.

The company already works with over 200 clinics and 1,700 transport service providers. The German company processes more than 50,000 transports each month. 

The platform offers real-time transparency, dynamic tour planning, and integration into existing hospital information systems (HIS).

Alexander Kunze, Managing Director at Qrago, says, “With this new financing, we will further develop our markets both horizontally and vertically – material and laboratory transports are just the beginning. We also see considerable potential in large-scale logistics for clinic networks. We plan to double our reach this year and enter the market in Austria and Switzerland.”